Unknown

Dataset Information

0

WISP-1 Promotes Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells Via the miR-153-3p/Snail Axis.


ABSTRACT: Around half of all patients with oral squamous cell carcinoma (OSCC) present with lymphatic metastasis, a strong predictor of poor survival. Improving survival rates depends on preventing the first step in the "invasion-metastasis cascade," epithelial-to-mesenchymal transition (EMT), and developing antilymphangiogenesis therapies that antagonize lymphatic metastasis. The extracellular matrix-related protein WISP-1 (WNT1-inducible signaling pathway protein-1) stimulates bone remodeling and tumor progression. We have previously reported that WISP-1 promotes OSCC cell migration and lymphangiogenesis induced by vascular endothelial growth factor C (VEGF-C). This investigation sought to determine the role of WISP-1 in regulating EMT in OSCC. Our analysis of oral cancer data from The Cancer Genome Atlas (TCGA) database revealed significant and positive associations between levels of WISP-1 expression and clinical disease stage, as well as regional lymph node metastasis. We also found higher levels of WISP-1 expression in serum samples obtained from patients with OSCC compared with samples from healthy controls. In a series of in vitro investigations, WISP-1 activated EMT signaling via the FAK/ILK/Akt and Snail signaling transduction pathways and downregulated miR-153-3p expression in OSCC cells. Our findings detail how WISP-1 promotes EMT via the miR-153-3p/Snail axis in OSCC cells.

SUBMITTER: Chang AC 

PROVIDER: S-EPMC6966565 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

WISP-1 Promotes Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells Via the miR-153-3p/Snail Axis.

Chang An-Chen AC   Lien Ming-Yu MY   Tsai Ming-Hsui MH   Hua Chun-Hung CH   Tang Chih-Hsin CH  

Cancers 20191129 12


Around half of all patients with oral squamous cell carcinoma (OSCC) present with lymphatic metastasis, a strong predictor of poor survival. Improving survival rates depends on preventing the first step in the "invasion<b>-</b>metastasis cascade," epithelial<b>-</b>to<b>-</b>mesenchymal transition (EMT), and developing antilymphangiogenesis therapies that antagonize lymphatic metastasis. The extracellular matrix<b>-</b>related protein WISP<b>-</b>1 (WNT1<b>-</b>inducible signaling pathway protei  ...[more]

Similar Datasets

| S-EPMC9275858 | biostudies-literature
| S-EPMC10134258 | biostudies-literature
| S-EPMC6949050 | biostudies-literature
| S-EPMC8331018 | biostudies-literature
| S-EPMC8040730 | biostudies-literature
| S-EPMC7425466 | biostudies-literature
| S-EPMC7453543 | biostudies-literature
| S-EPMC9052631 | biostudies-literature
| S-EPMC5596538 | biostudies-literature
| S-EPMC8939068 | biostudies-literature